Boundless Bio BOLD
NASDAQ BOLD
$2.59 +0.08 (+3.19%)
At close: Oct 1, 2026 · 4:00 PM EDT

Boundless Bio (BOLD) Net Equity Issued and Repurchased (2023 - 2025)

Updated

Boundless Bio's Net Equity Issued and Repurchased came in at $24,000 for Q4 2025.

Analysis

Boundless Bio (BOLD) Net Equity Issued and Repurchased (2023 - 2025) Analysis & Trends

For FY2025, Boundless Bio's Net Equity Issued and Repurchased was $141,000, down 99.8% from FY2024.

  • Going back by year, Net Equity Issued and Repurchased was $93 million in FY2024 (-6.7%) and $99.67 million in FY2023.
  • The Q4 2025 figure represents the highest quarterly Net Equity Issued and Repurchased since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Boundless Bio 56.41 Mn 56.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 24,000.00
Jun 30, 2024 92.94 Mn
Mar 31, 2024 59,000.00
Dec 31, 2023 -329,000.00
Jun 30, 2023 99.97 Mn
Mar 31, 2023 31,000.00
API Access

Boundless Bio Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BOLD&period=max&api_key=YOUR_API_KEY